SINGAPORE, Oct. 4, 2024 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) today announced a new strategic partnership with National University of Singapore (NUS), acting through the Yong Loo Lin School of Medicine (NUS Medicine), to establish the NUS-Agilent Center of Excellence (CoE) in Cell Metabolism, a scientific collaboration to advance cardiovascular and metabolic disease translational research over the next four years.
Register to read this story and more for free.
Signing up for an account helps us improve your browsing experience.
ContinueOR
See our subscription options.
Already have an account? Log in here